OVARIAN CANCER METASTATIC RECURRENT
Clinical trials for OVARIAN CANCER METASTATIC RECURRENT explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CANCER METASTATIC RECURRENT trials appear
Sign up with your email to follow new studies for OVARIAN CANCER METASTATIC RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for ovarian cancer: targeted drug T-DXd tested after standard treatments fail
Disease control Recruiting nowThis Phase 2 trial tests whether trastuzumab deruxtecan (T-DXd), a targeted antibody-drug conjugate, works better than standard chemotherapy for recurrent ovarian cancer that has stopped responding to PARP inhibitors. About 116 participants whose tumors express the HER2 protein w…
Matched conditions: OVARIAN CANCER METASTATIC RECURRENT
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New drug HWK-007 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-stage study tests a new drug called HWK-007 in people with advanced solid tumors, including certain ovarian, endometrial, and lung cancers. The drug is designed to target a protein (PTK7) found on cancer cells and deliver a chemotherapy-like payload directly to them. T…
Matched conditions: OVARIAN CANCER METASTATIC RECURRENT
Phase: PHASE1 • Sponsor: Whitehawk Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug cocktail targets hard-to-treat ovarian cancer in early trial
Disease control Recruiting nowThis phase 2 study is testing a combination of three drugs (disitamab vedotin, carboplatin, and bevacizumab) as first treatment and ongoing therapy for women with a specific type of advanced ovarian cancer that has a protein called HER2 and lacks a repair deficiency (HRD-negative…
Matched conditions: OVARIAN CANCER METASTATIC RECURRENT
Phase: PHASE2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC